NDC 66215-201 – Zavesca

Miglustat 100 mg/1 · Capsule · Oral

Human Prescription Drug

Product NDC66215-201

Product details

Brand name
Zavesca
Generic name
Miglustat
Labeler
Actelion Pharmaceuticals US, Inc.
Dosage form
Capsule
Route
Oral
Marketing category
NDA · NDA021348
Marketed since
July 31, 2003
Listing expires
December 31, 2026
Pharmacologic class
Glucosylceramide Synthase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Zavesca →

Package NDC codes (1)

Package NDCDescriptionSince
66215-201-906 BLISTER PACK in 1 CARTON (66215-201-90) / 15 CAPSULE in 1 BLISTER PACK (66215-201-15)Jul 31, 2003